CABA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Cabaletta Bio (CABA) Earnings Date & Reports

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CABA is expected to report earnings to -65 cents per share on May 14

Cabaletta Bio CABA Stock Earnings Reports

Q1'25

Est.

$-0.66

Q4'24

Missed

by $0.01

Q3'24

Missed

by $0.02

Q2'24

Missed

by $0.01

Q1'24

Missed

by $0.03

The last earnings report on March 31 showed earnings per share of -64 cents, missing the estimate of -63 cents. With 362.90K shares outstanding, the current market capitalization sits at 64.44M.

View a ticker or compare two or three

Compare

CABA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CABA
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2929 Arch Street

Phone

+1 267 759-3100

Employees

103

Web

https://www.cabalettabio.com